Vinayak S Joshi
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$6.3MFederal grants as PI12 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
12 awards · $6.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 13, 2024 | NIH | SBIR Phase I Automated system to improve compliance to diabetic retinopathy screening | $55K | VISIONQUEST BIOMEDICAL, LLC |
| Aug 30, 2023 | NIH | SBIR Phase I Automated system to improve compliance to diabetic retinopathy screening | $274K | VISIONQUEST BIOMEDICAL, LLC |
| Nov 23, 2020 | NIH | SBIR Phase II Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria | $1.0M | VISIONQUEST BIOMEDICAL, LLC |
| Dec 18, 2019 | NIH | SBIR Phase II Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria | $1.0M | VISIONQUEST BIOMEDICAL, LLC |
| Sep 10, 2019 | NIH | SBIR Phase II Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria | $412K | VISIONQUEST BIOMEDICAL, LLC |
| Dec 17, 2018 | NIH | SBIR Phase II Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria | $588K | VISIONQUEST BIOMEDICAL, LLC |
| Aug 14, 2017 | NIH | SBIR Phase II Comprehensive Assessment of Retinal Vasculature (CARV) | $37K | VISIONQUEST BIOMEDICAL, LLC |
| May 17, 2017 | NIH | SBIR Phase II Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria | $676K | VISIONQUEST BIOMEDICAL, LLC |
| Aug 25, 2016 | NIH | SBIR Phase II Comprehensive Assessment of Retinal Vasculature (CARV) | $570K | VISIONQUEST BIOMEDICAL, LLC |
| May 10, 2016 | NIH | SBIR Phase II Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria | $822K | VISIONQUEST BIOMEDICAL, LLC |
| Sep 21, 2015 | NIH | SBIR Phase II Comprehensive Assessment of Retinal Vasculature (CARV) | $689K | VISIONQUEST BIOMEDICAL, LLC |
| May 13, 2015 | NIH | SBIR Phase I Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria | $200K | VISIONQUEST BIOMEDICAL, LLC |
Peer ranks
Federal funding#188
Awards as PI#97
Patents#505
Companies
- VISIONQUEST BIOMEDICAL, LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.